Enova CEO exercises options, sells 41,000 shares at ~$125.6 — Form 4
Rhea-AI Filing Summary
David Fisher, Chief Executive Officer and Director of Enova International, Inc. (ENVA), reported option exercises and subsequent share sales on September 17 and September 19, 2025. Mr. Fisher exercised option rights at an exercise price of $23.96 to acquire 35,000 shares on 09/17/2025 and 6,000 shares on 09/19/2025. On the same dates he sold 35,000 shares (weighted-average sale price $125.5488) and 6,000 shares (weighted-average sale price $125.8924), respectively. The filings disclose the sales were executed in multiple trades at specified price ranges and note that the sale(s) were effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan. Following these transactions, Mr. Fisher’s reported beneficial ownership is 348,223 shares.
Positive
- Exercise and sale executed with clear disclosure including weighted-average prices and execution ranges
- Sales effected under Rule 10b5-1 trading plan, indicating preplanned compliance with insider trading rules
- Significant realized gain implied by exercise price of $23.96 and sale prices around $125.55–$125.89
Negative
- Insider sold 41,000 shares (35,000 on 09/17/2025 and 6,000 on 09/19/2025), reducing reported beneficial ownership to 348,223 shares
- Form 4 does not disclose the exact per-trade quantities and prices for each individual trade within the reported ranges (only weighted averages and ranges are provided)
Insights
TL;DR: CEO exercised options at $23.96 and sold 41,000 shares at ~ $125.55–$125.89, realizing substantial gains; final holding 348,223 shares.
These transactions are routine option exercises paired with open-market sales. The exercise price of $23.96 compared with weighted-average sale prices above $125 indicates a large intrinsic gain per share realized by the reporting person. The Form 4 discloses multiple-trade execution ranges and confirms use of a Rule 10b5-1 plan for the sale, which supports preplanned compliance with insider trading rules. For investors, the material facts are the sizes, prices, and resultant ownership level of 348,223 shares.
TL;DR: Insiders exercised long-dated options and sold shares under a 10b5-1 plan; disclosures appear complete with trade ranges provided.
The Form 4 includes the grant/exercise structure (options with limited SARs) and details on vesting and SAR exercise conditions. Providing weighted-average prices and ranges, and stating the sale was effected pursuant to a 10b5-1 plan, aligns with strong disclosure practice. The filing also explains the tandem nature of options and SARs and the vesting schedule. No governance or compliance shortfalls are evident from the information provided.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 6,000 | $0.00 | -- |
| Exercise | Common Stock, par value $0.00001 per share | 6,000 | $23.96 | $144K |
| Sale | Common Stock, par value $0.00001 per share | 6,000 | $125.8924 | $755K |
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 35,000 | $0.00 | -- |
| Exercise | Common stock, par value $0.00001 per share | 35,000 | $23.96 | $839K |
| Sale | Common stock, par value $0.00001 per share | 35,000 | $125.5488 | $4.39M |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $123.75 to $127.89. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $124.8055 to $127.23. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021, and February 12, 2022.
